Drug Trial News

RSS

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented by Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, at the 9th International Symposium on MDS currently taking place in Florence, Italy.

18 May 2007

Self-confidence pays dividends

Believing in yourself may be good for the soul, but it can also be good for the bank account, according to a new University of Florida study that finds self-confidence can translate into earning hundreds of thousands of dollars more over a lifetime.

18 May 2007

Study breaks link between lycopene and prostate cancer prevention

Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer.

18 May 2007

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

Peregrine Pharmaceuticals has announced it has filed a new clinical trial protocol with the FDA to study bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV).

18 May 2007

Study of normal brain development

Children appear to approach adult levels of performance on many basic cognitive and motor skills by age 11 or 12, according to a new study coordinated by the National Institutes of Health (NIH).

18 May 2007

Natural immune-control system may aid treatment of autoimmune disease and tissue rejection

The immune system's ability to police itself may offer a new method of arresting the cells responsible for autoimmune diseases such as multiple sclerosis and for the rejection of transplanted organs and tissues, scientists at Dana-Farber Cancer Institute report in a study in the May issue of the journal Immunity.

18 May 2007

Long-term treatment with anti-clotting drug clopidogrel improves stenting outcomes in diabetic patients

A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).

18 May 2007

Lowering a patient's temperature could aid standard stroke treatment

University of Cincinnati (UC) scientists have developed a model that could help physicians combine current clot-busting medication with below-normal body temperatures (hypothermia) to improve the treatment of ischemic stroke patients.

18 May 2007

Glucose plays a key role in enabling healthy beta cells

A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.

18 May 2007

Effects of Taser on human health

Using a Taser to control agitated suspects in police custody is standard operating procedure for many law enforcement agencies.

18 May 2007

Teaching decision-making skills

People who do well on a series of decision-making tasks involving hypothetical situations tend to have more positive decision outcomes in their lives, according to a study by decision scientists at Carnegie Mellon University and the RAND Corp.

18 May 2007

Substantial number of American adults hold fatalistic beliefs about cancer

If you feel that you are fated for cancer, your belief could turn into a self-fulfilling prophecy.

18 May 2007

Danube Pharmaceuticals starts trial of DNB-001 in patients with ocular hypertension

Danube Pharmaceuticals, Inc. has announced the initiation of a multi-center, randomized, double-blind, placebo controlled Phase II study with DNB-001 in 60 patients with ocular hypertension (elevated intraocular pressure).

18 May 2007

Some NSAIDs may be better suited to treating cancer

Until recently, nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin and celecoxib (sold as Celebrex), were being hailed as promising cancer prevention drugs.

18 May 2007

Circadian clock gene plays role in weight gain

Scientists at the University of Virginia and the Medical College of Wisconsin have discovered that a gene that participates in the regulation of the body's biological rhythms may also be a major control in regulating metabolism.

18 May 2007

One kilogram higher birth weight associated with a 10-20% reduced risk of heart disease later in life

Dr Rachel Huxley, lead author of the paper and Acting Director of Nutrition and Lifestyle at The George Institute said, "Although there was support for a small association between birth weight and an individual's future risk of heart disease, the relationship is not as strong as earlier studies have suggested.

18 May 2007